Stadnick Ellamae

All articles by Stadnick Ellamae

Drugs Used for Immunosuppression Post-transplant

General (including evidence of efficacy) Immunosuppression following cardiac transplantation Heart transplantation is a well-established therapeutic option for patients with end-stage heart disease.  The development of immunosuppressive agents has resulted in a dramatic improvement in the survival of heart transplant recipients, with 1- and 10-year survival rates approaching 90% and 50%, respectively. Despite this, there is a 25-30% risk of…

Next post in Cardiology